News & Blog

News & Blog

  • Reset
Blog | Jun 28 2021

Meet the Community – David (Dave) Arnold

Community
Blog | Jun 21 2021

Meet the Community – Leila Filgueiras

Community
Blog | Jun 14 2021

Meet The Community: Nikolaos Kotsomouras

Community
Blog | Jun 7 2021

Meet The Community: Scott Armit

Community
Blog | Jun 1 2021

Meet The Community: Silvana Camaj

Community
Blog | May 24 2021

Meet The Community: Silvany Guimarães Coelho Cotting

Community
News | May 21 2021

Larimar Therapeutics Announces $95 Million Private Placement Financing

Industry News
News | May 20 2021

Larimar Therapeutics Receives European Medicines Agency Priority Medicines (PRIME) Designation for CTI-1601 in Friedreich’s Ataxia

Industry News
Blog | May 17 2021

Meet The Community: Emily Young

Community
News | May 11 2021

Larimar Therapeutics Reports Positive Topline Phase 1 Clinical Trial Data Showing Dose-Dependent Increases in Frataxin Levels in Patients with Friedreich’s Ataxia

Industry News
News | May 10 2021

Larimar Therapeutics Reports First Quarter 2021 Operating and Financial Results

Industry News
Blog | May 10 2021

Meet The Community: Indiamara Zanandréa

Community